For clinics now using Ethos, the clinical and patient benefits are becoming increasingly clear
The use of online adaptive radiotherapy has expanded around the world since Varian introduced Ethos™ therapy at ASTRO in 2019. Through groups such as the Adaptive Intelligence Consortium, research continues to show that adaptive treatment can enable dose escalation and/or treatment margin reduction. Many clinicians see adaptive radiotherapy as transformative, not least because it uses the latest technology advances, such as artificial intelligence (AI) and machine learning, to create a new personalized treatment plan each time the patient is on the treatment couch.
Here we profile five clinics that have deployed Ethos therapy. Members of the clinical teams discuss their experiences with this approach, and the value they see it bringing to patients undergoing radiotherapy.
We also speak with Professor Patricia Price, a leading UK expert on radiotherapy, who shares her thoughts on the value and importance of adaptive radiotherapy treatment in the gradually receding shadow of the COVID pandemic.
Use the links below to access each profile/interview:
- The Treatment Adapts so the Patient Doesn’t Have To: Ethos at Queens Hospital, Romford, UK
- Icon Group, Australia: Choosing Adaptive Fractions 98 Percent of the Time
- Royal North Shore Hospital, Sydney, Australia: Adapting to Changes in the Target
- Henry Ford Health System, Detroit, Michigan: Looking Towards Adaptation During Five-Fraction SBRT
- Royal Surrey NHS Foundation Trust, Guildford, UK: Focusing on Patients Who Will Benefit Most
- Adaptive Radiotherapy Post-COVID: An Interview with Professor Patricia Price